financetom
Business
financetom
/
Business
/
Why Motorcar Parts Of America Shares Are Trading Lower Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Motorcar Parts Of America Shares Are Trading Lower Today
Jun 11, 2024 8:14 AM

Motorcar Parts Of America, Inc. ( MPAA ) shares are trading lower on Tuesday.

The company reported the fourth quarter net sales of $189.5 million compared with $194.7 million in the prior year. Sales missed the street view of $198.6 million.

Gross profit for the fourth quarter was $34.8 million compared with $36.2 million a year earlier. The gross margin for the fourth quarter was 18.4% compared with 18.6% a year earlier.

Operating income for the fourth quarter was $12.2 million compared with $23.7 million in the prior year.

“Our brake-related product categories continue to gain momentum, which will result in gross margin accretion. We remain focused on executing our strategic plans, supported by positive cash flow and neutralizing working capital,” said Selwyn Joffe, chairman, president, and chief executive officer.

The company exits the quarter with cash and equivalents worth $15.8 million.

The company reported adjusted earnings per share of 6 cents, missing the analyst consensus of 16 cents.

FY25 Outlook: Motorcar Parts of America ( MPAA ) expects net sales to be between $746 million-$766 million (consensus $766.3 million), representing 3.9%-6.7% year-over-year growth.

Price Action: MPAA shares are trading lower by 7.88% to $4.79 at last check Thursday.

Read Next: Tesla Rival Rivian Rolls Out Next-Gen R1S And R1T: Enhanced Performance, Design, And Tech Start At $69,900

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Celsius Holdings Stock Bounces Back From Steep Sell-Off
Celsius Holdings Stock Bounces Back From Steep Sell-Off
Nov 10, 2025
Celsius Holdings Inc ( CELH ) shares are moving higher Monday after the company announced a $300 million share repurchase authorization. CELH stock is racing ahead of the pack. See what the experts say here. What Happened: Celsius said its board approved a new buyback program to repurchase up to $300 million of its common stock. Repurchases may be made from...
Carbon Direct Acquires Pachama, Marking Major Milestone for Science-Driven Carbon Management
Carbon Direct Acquires Pachama, Marking Major Milestone for Science-Driven Carbon Management
Nov 10, 2025
The deal enhances Carbon Direct’s scientific expertise and client offerings by integrating Pachama’s innovative data and AI capabilities into Carbon Direct’s offerings. NEW YORK--(BUSINESS WIRE)-- Carbon Direct, the global leader in science-driven carbon management, announced today that it has acquired climate technology pioneer Pachama. The acquisition augments Carbon Direct’s world-class scientific expertise and advisory services with Pachama’s proprietary technology...
Rumble Stock Rises On Q3 Earnings: What You Need To Know
Rumble Stock Rises On Q3 Earnings: What You Need To Know
Nov 10, 2025
Rumble Inc ( RUM ) shares are rising Monday morning on the heels of the company’s third-quarter financial results. The company also announced new AI-related deals. Here’s what you need to know. RUM is delivering impressive returns. Review the technical setup here. What To Know: Rumble reported third-quarter revenue of $24.76 million, missing analyst estimates of $25.86 million, according to Benzinga...
Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease
Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease
Nov 10, 2025
(Reuters) -MeiraGTx Holdings ( MGTX ) has signed a deal with Eli Lilly ( LLY ), potentially worth over $475 million, granting the pharma giant rights to its experimental gene therapy for a rare, inherited disorder that causes severe vision loss from birth. Shares of the gene therapy developer rose 12.5% to $9.55 in premarket trading on Monday after the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved